606 related articles for article (PubMed ID: 19441926)
1. Patents of drugs extracted from Brazilian medicinal plants.
Balbani AP; Silva DH; Montovani JC
Expert Opin Ther Pat; 2009 Apr; 19(4):461-73. PubMed ID: 19441926
[TBL] [Abstract][Full Text] [Related]
2. Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives.
Dutra RC; Campos MM; Santos AR; Calixto JB
Pharmacol Res; 2016 Oct; 112():4-29. PubMed ID: 26812486
[TBL] [Abstract][Full Text] [Related]
3. Brazilian medicinal plants described by 19th century European naturalists and in the Official Pharmacopoeia.
Brandão MG; Zanetti NN; Oliveira P; Grael CF; Santos AC; Monte-Mór RL
J Ethnopharmacol; 2008 Nov; 120(2):141-8. PubMed ID: 18762237
[TBL] [Abstract][Full Text] [Related]
4. Patenting biotechnologies: the European Union Directive 98/44/EC of the European parliament and of the council of 6th July 1998 on the legal protection of biotechnological inventions.
Morelli Gradi G
Forum (Genova); 1999; 9(3 Suppl 3):25-36. PubMed ID: 10607844
[TBL] [Abstract][Full Text] [Related]
5. An ethnomedicinal survey on phytotherapy with professionals and patients from Basic Care Units in the Brazilian Unified Health System.
Oliveira SG; de Moura FR; Demarco FF; Nascente Pda S; Pino FA; Lund RG
J Ethnopharmacol; 2012 Mar; 140(2):428-37. PubMed ID: 22338646
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic activity of Brazilian Cerrado plants used in traditional medicine against cancer cell lines.
de Mesquita ML; de Paula JE; Pessoa C; de Moraes MO; Costa-Lotufo LV; Grougnet R; Michel S; Tillequin F; Espindola LS
J Ethnopharmacol; 2009 Jun; 123(3):439-45. PubMed ID: 19501276
[TBL] [Abstract][Full Text] [Related]
7. [Opportunities in the pharmaceutical industry and the local development logic based on the Brazilian biomes: the basis for a national policy discussion].
Villas Bôas Gde K; Gadelha CA
Cad Saude Publica; 2007 Jun; 23(6):1463-71. PubMed ID: 17546337
[TBL] [Abstract][Full Text] [Related]
8. Patenting bioactive molecules from biodiversity: the Brazilian experience.
Nogueira RC; de Cerqueira HF; Soares MB
Expert Opin Ther Pat; 2010 Feb; 20(2):145-57. PubMed ID: 20099999
[TBL] [Abstract][Full Text] [Related]
9. Is the use-impact on native caatinga species in Brazil reduced by the high species richness of medicinal plants?
de Albuquerque UP; de Oliveira RF
J Ethnopharmacol; 2007 Aug; 113(1):156-70. PubMed ID: 17616289
[TBL] [Abstract][Full Text] [Related]
10. Activities of the Pharmaceutical Technology Institute of the Oswaldo Cruz Foundation with medicinal, insecticidal and insect repellent plants.
Gilbert B; Teixeira DF; Carvalho ES; De Paula AE; Pereira JF; Ferreira JL; Almeida MB; Machado Rda S; Cascon V
An Acad Bras Cienc; 1999; 71(2):265-71. PubMed ID: 10412493
[TBL] [Abstract][Full Text] [Related]
11. Plants and animals utilized as medicines in the Jaú National Park (JNP), Brazilian Amazon.
Rodrigues E
Phytother Res; 2006 May; 20(5):378-91. PubMed ID: 16619367
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibition by Brazilian plants.
Braga FC; Serra CP; Viana NS; Oliveira AB; Côrtes SF; Lombardi JA
Fitoterapia; 2007 Jul; 78(5):353-8. PubMed ID: 17513067
[TBL] [Abstract][Full Text] [Related]
13. In vitro cytotoxic activity of Brazilian plant extracts against human lung, colon and CNS solid cancers and leukemia.
Suffredini IB; Paciencia ML; Varella AD; Younes RN
Fitoterapia; 2007 Apr; 78(3):223-6. PubMed ID: 17346903
[TBL] [Abstract][Full Text] [Related]
14. Patented antiinflammatory plant drug development from traditional medicine.
Darshan S; Doreswamy R
Phytother Res; 2004 May; 18(5):343-57. PubMed ID: 15173991
[TBL] [Abstract][Full Text] [Related]
15. Medicinal plants of the caatinga (semi-arid) vegetation of NE Brazil: a quantitative approach.
de Albuquerque UP; Muniz de Medeiros P; de Almeida AL; Monteiro JM; Machado de Freitas Lins Neto E; Gomes de Melo J; dos Santos JP
J Ethnopharmacol; 2007 Dec; 114(3):325-54. PubMed ID: 17900836
[TBL] [Abstract][Full Text] [Related]
16. Brazilian plants with possible action on the central nervous system: a study of historical sources from the 16th to 19th century.
Giorgetti M; Negri G; Rodrigues E
J Ethnopharmacol; 2007 Jan; 109(2):338-47. PubMed ID: 16982166
[TBL] [Abstract][Full Text] [Related]
17. Medicinal and poisonous diversity of the flora of "Cariri Paraibano", Brazil.
Agra MF; Baracho GS; Nurit K; Basílio IJ; Coelho VP
J Ethnopharmacol; 2007 May; 111(2):383-95. PubMed ID: 17236731
[TBL] [Abstract][Full Text] [Related]
18. The failure of pharmaceuticals and the power of plants: medicinal discourse as a critique of modernity in the Amazon.
Wayland C
Soc Sci Med; 2004 Jun; 58(12):2409-19. PubMed ID: 15081193
[TBL] [Abstract][Full Text] [Related]
19. Herbal drug patenting in India: IP potential.
Sahoo N; Manchikanti P; Dey SH
J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
[TBL] [Abstract][Full Text] [Related]
20. Central activity of hydroalcoholic extracts from Erythrina velutina and Erythrina mulungu in mice.
Vasconcelos SM; Macedo DS; de Melo CT; Paiva Monteiro A; Rodrigues AC; Silveira ER; Cunha GM; Sousa FC; Viana GS
J Pharm Pharmacol; 2004 Mar; 56(3):389-93. PubMed ID: 15025865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
